Literature DB >> 2529150

Steroid-induced dermal atrophy. Investigations on discontinuous application.

D Lubach1, A Bensmann, U Bornemann.   

Abstract

In this study several schedules of discontinuous application (DA) were tested, using various weak and strong topical corticosteroids (CS). The purpose of this study was to measure the influence of corticosteroids on skin thickness by means of a mechanical method. In a first experiment, betamethasone 17,21-dipropionate (Bet) and fluprednidene 21-acetate (Flu) were applied to the skin of the volar side of the forearm at a rhythm of 1:1 (1 day CS, 1-day interval) and 1:2 under occlusive dressing. The investigation period was 8 weeks. For comparison, Bet and Flu were applied continuously (CA) for 3 weeks. Flu thinned the skin to a lesser extent than Bet. With DA the skin was thinned to the same extent as with CA. In a second experiment, hydrocortisone 17-butyrate, betamethasone 17-valerate, desoxymethasone and hydrocortisone were tested. Here the treatment regimen was 5:9. The CS preparations were tested for 3 months on the volar side of the forearms under occlusive dressing. Skin thinning occurred during the 5 days of CS action and, in the beginning, receded again in the CS-free interval. However, this regressive process became weaker each time. At the end of the experiment the skin thinning persisted. With the exception of hydrocortisone, all CS tested produced statistically significant skin thinning after DA. The results of the investigation presented here show that thinning of the skin must also be expected with discontinuous application of topical CS.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2529150

Source DB:  PubMed          Journal:  Dermatologica        ISSN: 0011-9075


  8 in total

Review 1.  Topical corticosteroids. Which drug and when?

Authors:  B Giannotti; N Pimpinelli
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

Review 2.  Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis: review of randomised, double-blind clinical studies conducted in Japan.

Authors:  Hidemi Nakagawa
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

Review 3.  Skin conditions of baseball, cricket, and softball players.

Authors:  Joshua A Farhadian; Brook E Tlougan; Brian B Adams; Jonathan S Leventhal; Miguel R Sanchez
Journal:  Sports Med       Date:  2013-07       Impact factor: 11.136

Review 4.  Steroids versus nonsteroids in the treatment of cutaneous inflammation: therapeutic modalities for office use.

Authors:  E Panconesi; T Lotti
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

5.  Tacrolimus ointment: a novel and effective topical treatment of localized atopic dermatitis in a rhesus macaque (Macaca mulatta).

Authors:  Stéphanie L Torreilles; Richard H Luong; Stephen A Felt; Diane E McClure
Journal:  J Am Assoc Lab Anim Sci       Date:  2009-05       Impact factor: 1.232

Review 6.  Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs.

Authors:  Catharina M Lerche; Hans Christian Wulf
Journal:  Dermatol Reports       Date:  2010-09-14

7.  Topical Application of KAJD Attenuates 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis Symptoms Through Regulation of IgE and MAPK Pathways in BALB/C Mice and Several Immune Cell Types.

Authors:  Se Hyang Hong; Jin Mo Ku; Hyo In Kim; Tai Young Kim; Hye Sook Seo; Yong Cheol Shin; Seong-Gyu Ko
Journal:  Front Pharmacol       Date:  2019-09-19       Impact factor: 5.810

8.  Preventive effects of multi-lamellar emulsion on low potency topical steroid induced local adverse effect.

Authors:  Geun Dong Sul; Hyun Jung Park; Jong Hwan Bae; Keum Duck Hong; Byeong Deog Park; Jaesun Chun; Se Kyoo Jeong; Seung Hun Lee; Sung Ku Ahn; Hyun Jung Kim
Journal:  Ann Dermatol       Date:  2013-02-14       Impact factor: 1.444

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.